CITIC Construction Investment released a research report on the 24th stating that recovery can be expected under the optimization of epidemic prevention policies, and leading medical and aesthetic companies are full of resilience. Judging from overseas experience, medical and aesthetic demand will gradually recover under the optimization of the epidemic prevention policy. Considering domestic policy orientation and business resilience, we are optimistic about segments such as Aimei, Huaxi Biology, Huaxi Biology, East China Pharmaceutical, and Giant Biotech.
中信建投：医美需求将逐步复苏 头部公司韧性十足
CITIC Construction Investment: Medical and aesthetic demand will gradually recover, leading companies are resilient
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.